Carlomagno GroupCollaborations

Methodology for drug design
Sanofi Aventis, Frankfurt
C. Griesinger, MPI, Göttingen, Germany

RNA binders
A. Kirschning, University of Hannover, Germany

RNA dynamics
C. Griesinger, MPI Göttingen, Germany
M. Blackledge, IBS Grenoble, France

RNP complexes
R. Pillai, EMBL Grenoble, France
B. Reif, FMP, Berlin, Germany

Tubulin and proteasome binders
M. Kalesse, University of Hannover, Germany
K.H. Altmann, ETH, Zürich, Switzerland
C. Griesinger, MPI, Göttingen, Germany
F. Diaz, J.J. Barbero, J.M. Andreu, CSIC, Madrid, Spain

V-ATPase inhibitors
D. Menche, HZI Braunschweig, Germany
M.Huss, H. Wieczorek, University of Osnabrück, Germany